← Back to news
July 22, 2026

Senate Health Committee Advances $35 Insulin Price Cap Bill

  • The Senate Health Committee approved the INSULIN Act with a 17-5 vote, despite opposition from its chair.
  • The legislation aims to cap insulin prices at $35 per month for diabetes patients on private insurance.
  • Six Republicans joined Democrats in supporting the bill, reflecting a shift in GOP attitudes towards price controls.
  • The bill's future remains uncertain without a companion measure in the House.

2 Sources